Dr. Cutler holds a B.Sc. Mr. Diarmaid Cunningham is Chief Administrative Officer, General Counsel, Executive Vice President and Company Secretary. Aggregated news on COVID-19 clinical trials. In July 2016, Mr. Cunningham’s role expanded to include Chief Administrative Officer in addition to General Counsel. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. Ms. Poff has over 27 years of clinical research experience, almost all of which have been with ICON. Prior to ICON, Mr. McMillan held senior executive positions in a variety of service and consulting companies, most recently as CFO of PharmaNet Development Group. Clinical Research Services. Gareth Arnold Creating a world leader in healthcare intelligence and clinical research. Dr. Murphy also has over a decade of experience in therapeutics having led the CNS and internal medicine project management divisions for Quintiles. Prior to ICON, Ms. Poff was at ClinTrials Research and she also has experience in neonatal and paediatric nursing, having worked at Vanderbilt University Hospital. With the largest Pharmaceutical market in the world, and hundreds of opportunities to get involved in, there's no better place to advance your career- and no better company to do it than ICON. Mr. McMillan was also CEO of BMG Direct, the North American music distribution division of Bertelsmann, A.G., and CFO/COO of Renaissance Solutions, a strategic consulting and technology services company. It has a circulating supply of 592,430,027 ICX coins and the max. Ms. Dana Poff is Executive Vice President, Program Management and is a member of ICON’s Leadership Team. Site web inactif Institut de beauté à Pointe à Pitre : Icon Paris. Mr. Barry Balfe is President of ICON Functional Services (IFS). suit small local trials or large global programs. The live ICON price today is . Mr. Holmes has an MBA from Smurfit Business school and is a graduate of Cambridge University and the University of East Anglia. We have extensive experience in a broad range of therapeutic areas. A member of ICON’s Leadership Team he is also involved in strategy development and business planning. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators. The integration of MedPass International’s services brings noted expertise in complex class 3 medical devices, interventional cardiology and structural heart devices. Prior to joining the Company, Mr. Cunningham spent 10 years with A&L Goodbody, one of Ireland's premier corporate law firms. garnold@webershandwick.com, Decentralised & hybrid clinical solutions, Webinar: Transforming CNS drug development with wet lab and imaging biomarker solutions. ICON plc is a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. Thorough collection and assessment of product safety information is essential to the success of both clinical research studies and in maintaining post-marketing product licenses. Commercialisation During her tenure, Dr. Murphy published extensively in eminent peer reviewed journals. Ms. Buck joins ICON from Optum Insights (part of the United Healthcare group) where she was SVP & Chief of Clinical Development. +33 (0)1 42 12 83 30 [email protected] 1950 Studebaker Starlight Commander Coupe. Ms. Poff has over 27 years of clinical research experience, almost all of which have been with ICON. You’ll be working in a great environment, with some of the brightest and the friendliest people in the sector, and you’ll be helping shape an industry in one of the most exciting Clinical Research markets in the EU: France. As a global provider of drug development solutions, our work is serious business. News & Events. Mr. James Miskel holds management responsibility for ICON’s central laboratories, specialty laboratories, bioanalytical laboratories, and early clinical development services. “The medical device CRO market is experiencing strong growth due to technical innovation, changing regulations and increasing levels of outsourcing. With headquarters in Dublin, Ireland, ICON currently operates from 97 locations in 40 countries and has approximately 14,650 employees as at December 31, 2019. DERELICT. ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. ICON is committed to making a positive impact on our people, environment and our community. This expansion of his role means Mr. Cunningham has responsibility to the Company’s Quality Assurance, Client Contracts Services, Facilities and Procurement groups in addition to his responsibility for the Company’s Legal group. MedPass has helped to advance the development of breakthrough medical device technologies by offering a broad range of strategic and operational services tailored to meet the needs of clients around the globe. The company has served more than 1,000 medical device companies, from start-ups to multi-nationals, and has contributed to the development of hundreds of innovative devices including a number of breakthrough technologies. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators. We specialise in the strategic development, management and analysis of programs that support Clinical Development; from compound selection to Phase I-IV clinical studies. Telephone: (+44) 0207 418 0398 Founded in 1991 by Sarah Sorrel, MedPass is the leading European Medical Device CRO and Regulatory and Reimbursement Consultancy. He also served as CEO of Palladium Group, a global leader in corporate performance management software and consulting; CFO and CEO of CMGI, the internet holding company, for which he was named Mass HighTech Turnaround CEO of the Year. Read more. Bénéficiez de votre réseau professionnel et changez de travail ! This is an exciting opportunity to join ICON Clinical Trial Manager / Senior Clinical Trial Manager Based anywhere in Europe including home-based CNS Are you an expert global Clinical Trial Manager with a specialism in CNS…Have you overseen clinical operations on global trials? With our vision to be the partner of choice in drug development, we hire only the best and brightest in the industry. 1961 Dodge Long Bed. An Iconic Team. Mr. Cunningham joined the Company as General Counsel in November 2009. BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. Dr. Cutler served as Group President, Clinical Research Services from November 2011 until his appointment as Chief Operating Officer. Mr. Cronin has a Bachelor of Business degree with a major in Human Resources, from the University of Limerick. We are currently working on a number of COVID-19 vaccine trials. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. George holds a Bachelor of Arts degree in Economics from Stanford University, a Doctor of Law from Harvard Law School and a Masters of Business Administration from Harvard Business School. But that doesn't mean you can't have fun while you do it. As part of the DOCS team, Mr. Balfe served as Senior Vice-President, Global Program Management where he oversaw operational design, planning & delivery within DOCS' resourcing & FSP businesses. REFORMER. drugs and devices that save lives and improve quality of life. Chief Administrative Officer, General Counsel & Company Secretary. 1950 Packard Coupe. Mr. O'Leary holds a Degree in Medicinal Chemistry and a Masters in Data Management. We have extensive experience in a broad range of therapeutic areas. Flaticon, the largest database of free vector icons. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Prior to joining ICON, Ms. Boericke held positions with several clinical research organisations (CROs), including ClinTrials, Quintiles, INC Research, Duke Clinical Research Institute, and i3. Mr. Brennan qualified as a chartered accountant with PricewaterhouseCoopers and obtained a Bachelor’s degree in Accounting and Finance from Dublin City University. About ICON. and a Ph.D from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK). CONCEPTS. $1.93 USD with a 24-hour trading volume of $722,826,172 USD.. ICON is up 9.22% in the last 24 hours. Prior to joining ICON, Dr. Cutler held the position of Chief Executive Officer of Kendle having previously served as Chief Operating Officer. From 1994-2001 Mr. O'Leary worked for SmithKline Beecham and later GlaxoSmithKline and held positions in Data Management, Project Management and Resource Management. ... Chief Executive Officer, ICON plc. Bringing the clinical trial to the patient with innovation and in-home solutions. 1,110 ICON reviews. Ms. Kim Boericke was appointed President of ICON Commercialisation and Outcomes Services in January 2019, having previously served as Executive Vice President, Global Program Management since 2014, where she was responsible for a number of therapeutic units (Oncology, Cardiovascular/Metabolic Diseases, CNS and Aging Diseases, Rare Diseases, Infectious Disease and Vaccines, Internal Medicine and Immunosciences, and Biosimilars). Founded in 1991 and headquartered in Paris, MedPass International is the leading European Medical Device CRO and consultancy. Mr. Balfe was previously EVP, Global Business Development. Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017 having previously served as Chief Operating Officer from January 2014 to March 2017. Ms. Boericke graduated with a Bachelor of Science degree from Duke University in 1989. Decentralised & hybrid clinical solutions, Webinar: Transforming CNS drug development with wet lab and imaging biomarker solutions. Read more. ICON’s services within this area include project management, clinical operations/monitoring, patient centric monitoring and data management. The company has served more than 1,000 medical device companies, from start-ups to multi-nationals, and has contributed to the development of hundreds of innovative devices including a number of breakthrough technologies. Whether you fancy the bright lights of Paris or … ICON provides analysis and key insights on these challenges, with practical advice and recommendations. Domiciliée à NANTERRE (92000), elle est spécialisée dans le secteur d'activité de la recherche-développement en autres sciences physiques et naturelles.Son effectif est compris entre 100 et 199 salariés. ICON is a global Clinical Research Organisation with exciting opportunities all over the world- and there's nowhere more exciting to work than in the US. Dr. Murphy has over 20 years’ experience within the pharmaceutical and CRO industry. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies and device development from early phase product development through pre-market and commercialization studies. Mr. Balfe holds a Bachelor of Science degree in chemistry, having studied at Dublin City University and Ecole Nationale Supérieure de Chimie de Toulouse. This press release contains forward-looking statements. We safely manage early-phase studies from First-in-Human to proof of concept. Our mission is to help clients accelerate the development of Weber Shandwick ICON Clinical Research Principal, Health Economics Flexible to be Home Based in UK or US (East Coast) This is an opportunity to work for ICON Global HTA, Health … Mr. O'Leary joined the company in Feb-2001 as Manager of Data management in Dublin, Mr. O'Leary subsequently went on to set-up ICON's process improvement initiative "IMPROVE" and returned to Data Management to become EU VP of Data Management before becoming Global Head of Data Management in 2006. En poursuivant votre navigation, vous acceptez l'utilisation de cookies.J'ai compris. Connecting patients with the right trial in the right location. Ms. Buck is a board certified and licenced physician from the Pennsylvania State University School of Medicine, and completed her Internship and Residency in Internal Medicine at Abington Memorial Hospital, before working as a primary care practitioner in a private practice. Prior to joining ICON, Mr. Brennan developed his corporate finance experience in Cement Roadstone Holdings, a major Irish building materials organization. Ms. Dana Poff is Executive Vice President, Program Management and is a member of ICON’s Leadership Team. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. Mr. George A. McMillan is Chief Commercial Officer of ICON. Ms. Buck led the clinical operations and regulatory groups to create a Real-World Evidence and Outcomes clinical trial business. ICON CLINICAL RESEARCH SARL, société à responsabilité limitée est active depuis 22 ans. Clinical Research Associate II (Current Employee) - Houston, TX - February 3, 2020 Working is ICON has been a great experience. In her role, Ms. Poff has global responsibility for the delivery of ICON’s clinical research programs across all therapeutic areas. Mr. O'Leary is ICON's Chief Information officer previous to this he held the position of President of ICON Central Laboratories. Founded in 1991 and headquartered in Paris, MedPass International is the leading European Medical Device CRO and consultancy. A roadmap to meet 2022 deadlines, while navigating pandemic disruptions. ICON is certainly one to watch for giving other CRO giants like IQVIA competition for this key driver in clinical development. Executive Vice President, Corporate Development. PRA Health Sciences Insights . development and commercialisation, and can be adapted to Download over 1,569 icons of paris in SVG, PSD, PNG, EPS format or as webfonts. ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are available on the SEC's website at http://www.sec.gov. Patient focused research for better outcomes. Mr. McMillan joined ICON in 2012 as Executive Vice President of Finance Operations, a position he held until he was appointed Chief Commercial Officer in March 2017. Creating a world leader in healthcare intelligence and clinical research. Prior to this, Dr. Murphy served as Executive Vice President of clinical and data operations globally. This addition broadens our medical device footprint and staff headcount across Europe, positioning us among the global leaders in this market.”. He joined ICON with an initial focus on central laboratories in November 2013, after executive positions in general and operations management at Wyeth Pharmaceuticals and CROs MDS Pharma Services and Harlan Laboratories. Mr. Balfe has been with ICON for over fifteen years and has held a number of senior roles, predominantly within the DOCS organisation, where he has successfully grown this business and has developed and led a number of new strategic partnerships. President of ICON Commercialisation and Outcomes Services. 1965 Ford Short Bed Step Side Pick Up. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. Dr. Murphy joined ICON in 2012 from Quintiles where she led a clinical and data management workforce (since 2009). …The role As a Clinical Trial Manager you would be expected to recognize the importance of and… Mr. Holmes joined ICON in 2005 originally as VP of Marketing and Market Development and took responsibility for Corporate Development in 2006. Serving governments, multinational public health organisations, and global NGOs. We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs. Mr. Cronin also spent time early in his career with the General Motors (GM) Corporation and the Computer Sciences Corporation (CSC). Serving governments, multinational public health organisations, and global NGOs. Study Start Up Associate I, ICON Clinical Research (Former Employee) - North Wales, PA - April 26, 2018 The 401k plan is dynamite- 100% fully vested from day 1 with a 100% match up to 6%. We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs. More information. De nouvelles offres d’emploi “Icon Plc” sont ajoutées tous les jours. Mr. Brendan Brennan has served as Chief Financial Officer since February 2012. Sur l'année 2019 elle réalise un chiffre d'affaires de 25563100,00 EU. With travel restrictions due to COVID-19, FIRECREST helps deliver and manage remote training for investigators. The San Antonio Clinical Research Unit is a customised site for clinical trials. MedPass is headquartered in Paris and delivers its services through a team of around 100 staff (a mix of full-time and contract staff). Institut de beauté à Pointe à Pitre : Icon Paris. Further information is available at www.iconplc.com. Dr. Nuala Murphy has been President of ICON Clinical Services at ICON since January 2014. In her role, Dana has global responsibility for the delivery of ICON’s clinical research programs across all therapeutic areas. top notch training. Mr. Miskel spent his early career as a management consultant with McKinsey & Company leading engagements in growth strategy, operational improvement, and merger integration for clients in pharmaceuticals, medical devices, and several other sectors. Connecting patients with the right trial in the right location. Icon Group proudly brings together Icon Cancer Centre, Epic Pharmacy, Slade Health and Slade Pharmacy to deliver the best possible care, close to home. Mr. O'Leary is a graduate of Kingston University in Surrey and a Member of the Royal Society of Chemistry. The current CoinMarketCap ranking is #63, with a live market cap of $1,144,372,770 USD. She started as a Project Manager and moved her way up into jobs with more responsibility covering Program Management, Monitoring, Feasibility and Start Up, Functional Outsourcing, and Account Management running regions and global operations. ICON provides analysis and key insights on these challenges, with practical advice and recommendations. ICON TR. Mr. Holmes leads ICON’s M&A strategy from target identification to deal close and in his time at ICON has led the acquisition of 16 companies. He holds BS and MS degrees in engineering from the Massachusetts Institute of Technology along with an MBA from the Wharton School and an MA in International Studies from the University of Pennsylvania. ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards. With travel restrictions due to COVID-19, FIRECREST helps deliver and manage remote training for investigators. From 2009 until 2013, Mr. Cunningham was based in the Company’s global headquarters in Dublin. ICON is a Global Contract Research Organisation (CRO). Bringing the clinical trial to the patient with innovation and in-home solutions. 1947 Hudson Big Boy Pick Up. Mr. Brennan joined ICON in 2006 and he has served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. Dr. Murphy served in the field of late phase clinical research at Benefit International. This acquisition, concluded in late January, further enhances ICON’s Medical Device and Diagnostic Research Services, through the addition of new regulatory and clinical capabilities in Europe. ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. ICON has recently led the development of 17 vaccines resulting in FDA/EMA approvals. Ms. Buck spent time working at AstraZeneca in clinical development and in its Innovative Medicines group. 1960 Mercedes 300D. ICON Clinical Research Are you a dynamic, organized, rigorous Senior CRA, and want to join a dynamic team in France? A Medical Device CRO based in Europe -MedPass International has EU Full Services of regulatory, clinical services, CE marking, market access, reimbursement. We have a wide range of jobs in Clinical Research, Pharmaceutical and Medical jobs, search our website and apply online to start your career with us. We are currently working on a number of COVID-19 vaccine trials. President of ICON Laboratory & Early Phase Services. ICON provides its full range of clinical, consulting and commercial services across several industry sectors. ICON has recently led the development of 17 vaccines resulting in FDA/EMA approvals. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. She has extensive experience in managing drug development from Phase I through post marketing. ... Clinical research specialists will match you with studies that may be an option for your medical condition. ICONs Clinical Operations team is actively looking to hire a significant number of In-house CRAs. Founded in 1991 and headquartered in Paris, MedPass International is the leading European Medical Device CRO and consultancy. Location: Office based in Paris - Nanterre. Ms. Poff left ICON in 2017 to become Chief Operating Officer of a life science technology company, before re-joining ICON in January 2019 to take up her current role. In 2013, Mr. Cunningham was seconded to the Company’s US headquarters in Pennsylvania and that secondment ended in 2018 when Mr. Cunningham returned to Dublin. suit small local trials or large global programs. If you enjoy travel, are ready for your next step in … 59 Icon PLC jobs available on Indeed.com. ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards. ICON is committed to making a positive impact on our people, environment and our community. drugs and devices that save lives and improve quality of life. Sarah Sorrell, President and CEO, MedPass International, said: “As the leader in Medical Device Regulation and Clinical Development in Europe, MedPass is delighted to be joining ICON to become the global service provider of choice in Medtech Devices and Diagnostics.”, “The acquisition of MedPass International deepens our existing advisory capabilities, particularly in medical device regulation,” commented Dr. Steve Cutler, Chief Executive Officer, ICON plc. At ICON, it's our people that set us apart. A growing international CRO in the Top world leaders Mr. Cunningham served as Secretary to the Board of the Association of Clinical Research Organizations (ACRO) in 2013 and 2014. 1970 Land Rover Series IIA. Dr. Cutler was appointed to the Board of Directors in November 2015. Our mission is to help clients accelerate the development of ICON provides its full range of clinical, consulting and commercial services across several industry sectors. Between 2013 and 2017 he also had responsibility for ICON’s Investor Relations functions. Her experience ranges over multiple therapy areas including GI, neuroscience, dermatology, ophthalmology, oncology, cardiovascular/metabolic, immunology, renal, women’s health, orphan diseases, liver, and psychiatry. Dublin, Ireland, 19th February 2020 – ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced that it has acquired MedPass International, the leading European medical device CRO, regulatory and reimbursement consultancy, that specialises in medical device development and market access. More details on MedPass can be found on the company website http://medpass.org. AVAILABLE PROJECTS. He initially joined ICON’s Business Development team in 2003, before taking on the leadership of DOCS' US Business in early 2007 and subsequently overseeing DOCS' European Operations. THE WATCH. Mr. Cronin joined ICON in 2014. Mr. Joe Cronin is Chief Human Resources Officer, responsible for designing and implementing people practices and building organisational leadership and culture that enable ICON to execute its strategy. IQVIA You will be part of our world class development program which fast tracks your growth into a traveling CRA within 4-6 months. work life balance isnt so … The company has served more than 1,000 medical device companies, from start-ups to multi-nationals, and has contributed to the development of hundreds of innovative devices including a number of breakthrough technologies. In 2018 he was recognised as 'CIO of the Year' by the Irish Tech Awards. Apply to Client Services Associate, Ihcra, Clinical Research Coordinator and more! In her role, Ms. Poff has global responsibility for the delivery of ICON’s clinical research programs across all therapeutic areas. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. Dana has over 27 years of clinical research experience, almost all of which have been with ICON. Ms. Dana Poff is Executive Vice President, Program Management and is a member of ICON’s Leadership Team. development and commercialisation, and can be adapted to Mr. Cronin has almost 20 years of HR experience in a variety of global industries, including ten years at the Kellogg company in a number of regional and global HR leadership roles. Seamless transparent pharmacovigilance solutions . Covance by Labcorp, prestataire de recherche sous contrat et société de services de développement de médicaments, a aidé à la mise sur le marché des 50 médicaments les mieux vendus.